Skip to main
BRNS

BRNS Market Capitalization Overview

Market Cap: $31.01M as of Jan 9, 2026

$31.01M
$3.34M (12.04%)past month
As of Jan 9, 2026, BRNS has a market capitalization of $31.01M. Over the past 30 days, its market cap has decreased by -3.9%, while in the last 12 months, it has increased by 8.48%.

Market capitalization represents the total value of Barinthus Biotherapeutics PLC as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

BRNS Market Cap Formula = Stock Price * Shares Outstanding

The market cap of BRNS helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

BRNS Market Cap History

DateMarket CapChange
Dec 1, 2025$31.23M-34.97%
Nov 3, 2025$48.02M-20.40%
Oct 1, 2025$60.33M+27.45%
Sep 2, 2025$47.33M-16.20%
Aug 1, 2025$56.48M+55.56%
Jul 1, 2025$36.31M-15.89%
Jun 2, 2025$43.17M-1.58%
May 1, 2025$43.86M+35.45%
Apr 1, 2025$32.38M-15.59%
Mar 3, 2025$38.36M-2.51%
Feb 3, 2025$39.35M-19.76%
Jan 2, 2025$49.04M+26.21%

BRNS End of Year Market Cap History

DateMarket CapChange
2026$31.01M+8.48%
2025$28.59M-40.16%
2024$47.77M-66.42%
2023$142.24M+62.31%
2022$87.64M-77.02%
2021$381.39M

FAQs About Barinthus Biotherapeutics PLC (BRNS) Market Cap

As of Jan 9, 2026, the market capitalization of BRNS is $31.01M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Barinthus Biotherapeutics PLC’s market capitalization has increased by 12.04%, changing from $27.68M to $31.01M as of Jan 9, 2026.

In the last 3 months, Barinthus Biotherapeutics PLC’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Barinthus Biotherapeutics PLC’s market capitalization decreased from $47.77M in January to $28.59M in December, reflecting a -40.16% change.

In the past five years, BRNS has had a compound annual growth rate (CAGR) of -40.44% in market capitalization. This means its market cap has shrunk at an average rate of -40.44% per year.

Barinthus Biotherapeutics PLC (BRNS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.